Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125732262 | 12573226 | 2 | F | 20160818 | 20160720 | 20160831 | EXP | GB-MHRA-ADR 23557896 | GB-ACCORD-042497 | ACCORD | 0.00 | F | Y | 0.00000 | 20160831 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125732262 | 12573226 | 1 | PS | RAMIPRIL. | RAMIPRIL | 1 | STARTED WITH 2.5 MG AND INCREASED TO 5 MG | N | 202392 | 5 | MG | ||||||||
| 125732262 | 12573226 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | U | 0 | 600 | MG | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125732262 | 12573226 | 1 | Product used for unknown indication |
| 125732262 | 12573226 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125732262 | 12573226 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125732262 | 12573226 | Blood pressure increased | |
| 125732262 | 12573226 | Cough | |
| 125732262 | 12573226 | Diarrhoea | |
| 125732262 | 12573226 | Influenza | |
| 125732262 | 12573226 | Muscle spasms | |
| 125732262 | 12573226 | Nail disorder | |
| 125732262 | 12573226 | Nasopharyngitis | |
| 125732262 | 12573226 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |